Xulong Wang is an experienced clinical statistician currently serving as Director at Karyopharm Therapeutics Inc., with previous roles as Associate Director and Senior Manager, where responsibilities included overseeing statistical aspects of multiple clinical studies and regulatory submissions from Phase 1 to Phase 3. Prior to Karyopharm, Xulong Wang held positions at Merck as Senior Scientist, focusing on genetics and data science for target identification, and at GNS Healthcare as Principal Scientist, utilizing advanced analytical methods on biomedical data. Additional experience includes working as a Data Scientist at Eisai US and as a Postdoctoral Associate at The Jackson Laboratory and the University of California at San Diego, with a strong background in computational genetics and neural system development. Xulong Wang earned a Ph.D. in Biomedical Engineering from Shanghai Jiao Tong University and a Bachelor's degree in Engineering Physics from Xidian University.